FDA.reportPublic FDA data

CALCIPOTRIENE

Substance profile for UNII 143NQ3779B, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for CALCIPOTRIENE
Structure render from PubChem CID 5288783

Substance Identity#

UNII
143NQ3779B
Preferred term
CALCIPOTRIENE
Registry number
112965-21-6
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C27H40O3
Chemical structure for CALCIPOTRIENE
Structure render from PubChem CID 5288783

Chemical And Database Identifiers#

InChIKey
LWQQLNNNIPYSNX-UROSTWAQSA-N
SMILES
C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]2CC[C@@H]3[C@]2(C)CCC\C3=C/C=C4/C[C@@H](O)C[C@H](O)C4=C
RxCUI
29365
PubChem
5288783
NCIt
C28900
INN ID
6376

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound5288783pubchem.ncbi.nlm.nih.gov/compound/5288783
PubChem InChIKey SearchLWQQLNNNIPYSNX-UROSTWAQSA-Npubchem.ncbi.nlm.nih.gov/#query=LWQQLNNNIPYSNX-UROSTWAQSA-N
RxNorm29365mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=29365
NCI ThesaurusC28900ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28900
FDA Substance Registration System143NQ3779Bprecision.fda.gov/uniisearch/srs/unii/143NQ3779B

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE MOIETYThese highlights do not include all the information needed to use Taclonex ® Ointment safely and effectively. See Full Prescribing Information for Taclonex ® Ointment. Taclonex ® (calcipotriene 0.005% and betamethasone dipropionate 0.064%) Ointment For topical use only Initial U.S. Approval: 2006.4
ACTIVE MOIETYThese highlights do not include all the information needed to use Taclonex Scalp® Topical Suspension safely and effectively. See full prescribing information for Taclonex Scalp® Topical Suspension. Initial U.S. Approval: 20061
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Taclonex Scalp® Topical Suspension safely and effectively. See full prescribing information for Taclonex Scalp® Topical Suspension. Initial U.S. Approval: 20061
ACTIVE INGREDIENTDovonex ® (calcipotriene cream) Cream, 0.005%1
ACTIVE MOIETYDovonex ® (calcipotriene cream) Cream, 0.005%1
ACTIVE INGREDIENT1c02cc96-ecaa-467b-9acb-7cae57ec8e874
ACTIVE MOIETY1c02cc96-ecaa-467b-9acb-7cae57ec8e874
ACTIVE MOIETYTACLONEX (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE) SUSPENSION [LEO PHARMA INC.]15
ACTIVE INGREDIENTSORILUX (CALCIPOTRIENE) AEROSOL, FOAM [STIEFEL LABORATORIES INC]11
ACTIVE MOIETYSORILUX (CALCIPOTRIENE) AEROSOL, FOAM [STIEFEL LABORATORIES INC]11
ACTIVE MOIETYTACLONEX (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE) OINTMENT [LEO PHARMA INC.]7
ACTIVE INGREDIENTDOVONEX (CALCIPOTRIENE) CREAM [LEO PHARMA INC.]6
ACTIVE MOIETYDOVONEX (CALCIPOTRIENE) CREAM [LEO PHARMA INC.]6
ACTIVE MOIETYCALCIPOTRIENE 0.005% AND BETAMETHASONE DIPROPIONATE 0.064% OINTMENT [SANDOZ INC.]4
ACTIVE INGREDIENTCALCIPOTRIENE 0.005% AND BETAMETHASONE DIPROPIONATE 0.064% OINTMENT [SANDOZ INC.]4
ACTIVE MOIETYCALCIPOTRIENE SOLUTION [HI-TECH PHARMACAL CO., INC.]4
ACTIVE INGREDIENTDOVONEX (CALCIPOTRIENE) SOLUTION [LEO PHARMA INC.]4
ACTIVE MOIETYDOVONEX (CALCIPOTRIENE) SOLUTION [LEO PHARMA INC.]4
ACTIVE INGREDIENTDOVONEX (CALCIPOTRIENE) SOLUTION [WARNER CHILCOTT (US), LLC]4
ACTIVE MOIETYDOVONEX (CALCIPOTRIENE) SOLUTION [WARNER CHILCOTT (US), LLC]4
ACTIVE INGREDIENTCALCIPOTRIENE (CALCIPOTRIENE) SOLUTION [G&W LABORATORIES, INC.]3
ACTIVE MOIETYCALCIPOTRIENE (CALCIPOTRIENE) SOLUTION [G&W LABORATORIES, INC.]3
ACTIVE MOIETYCALCIPOTRIENE OINTMENT [GLENMARK PHARMACEUTICALS INC., USA]3
ACTIVE INGREDIENTCALCIPOTRIENE OINTMENT [GLENMARK PHARMACEUTICALS INC., USA]3
ACTIVE MOIETYCALCIPOTRIENE SOLUTION [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]3
ACTIVE INGREDIENTCALCIPOTRIENE SOLUTION [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]3
ACTIVE INGREDIENTDOVONEX (CALCIPOTRIENE) CREAM [WARNER CHILCOTT (US), LLC]3
ACTIVE MOIETYDOVONEX (CALCIPOTRIENE) CREAM [WARNER CHILCOTT (US), LLC]3
ACTIVE INGREDIENTTACLONEX (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE) OINTMENT [WARNER CHILCOTT (US), LLC]3
ACTIVE MOIETYTACLONEX (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE) OINTMENT [WARNER CHILCOTT (US), LLC]3
ACTIVE MOIETYCALCIPOTRIENE CREAM [PRASCO LABORATORIES]2
ACTIVE INGREDIENTCALCIPOTRIENE CREAM [PRASCO LABORATORIES]2
ACTIVE INGREDIENTCALCIPOTRIENE OINTMENT [PRASCO LABORATORIES]2
ACTIVE MOIETYCALCIPOTRIENE OINTMENT [PRASCO LABORATORIES]2
ACTIVE MOIETYCALCIPOTRIENE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.]2
ACTIVE INGREDIENTCALCIPOTRIENE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.]2
ACTIVE MOIETYCALCIPOTRIENE SOLUTION [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]2
ACTIVE INGREDIENTCALCIPOTRIENE SOLUTION [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]2
ACTIVE MOIETYCALCITRENE (CALCIPOTRIENE) OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.]2
ACTIVE INGREDIENTCALCITRENE (CALCIPOTRIENE) OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.]2
ACTIVE MOIETYENSTILAR (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE) AEROSOL, FOAM [LEO PHARMA INC.]2
ACTIVE MOIETYTACLONEX SCALP (CALCIPOTRIENE 0.005% AND BETAMETHASONE DIPROPIONATE 0.064%) SPRAY, METERED [WARNER CHILCOTT (US), LLC]2
ACTIVE INGREDIENTTACLONEX SCALP (CALCIPOTRIENE 0.005% AND BETAMETHASONE DIPROPIONATE 0.064%) SPRAY, METERED [WARNER CHILCOTT (US), LLC]2
ACTIVE INGREDIENTCALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE OINTMENT [PERRIGO NEW YORK INC]1
ACTIVE MOIETYCALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE OINTMENT [PERRIGO NEW YORK INC]1
ACTIVE INGREDIENTCALCIPOTRIENE CREAM [GLENMARK PHARMACEUTICALS INC.,USA]1
ACTIVE MOIETYCALCIPOTRIENE CREAM [GLENMARK PHARMACEUTICALS INC.,USA]1
ACTIVE MOIETYCALCIPOTRIENE CREAM [SANDOZ INC.]1
ACTIVE INGREDIENTCALCIPOTRIENE CREAM [SANDOZ INC.]1